Ferring's Muted Fertility Drug Recall Falls Within FDA Rules

By Sindhu Sundar (October 15, 2015, 9:23 PM EDT) -- Ferring Pharmaceuticals has recalled fertility medication Bravelle with so little fanfare that it is mostly fertility clinics and pharmacies that have informed patients seeking refills, but attorneys say the drugmaker is nonetheless well-positioned to ward off potential consumer suits because its approach meets recall guidelines for problems related to effectiveness rather than safety....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!